Abstract
According to the WHO World Cancer Report, 2003. breast cancer is a global public health burden with more than one million new cases diagnosed worldwide each year. Despite the diminished frequency of advanced-stage disease at initial diagnosis in some parts or the world, a significant proportion of women with early-stage disease eventually experience distant recurrences. Metastatic breast cancer is generally incurable and treatment is aimed of extending survival and improving quality-of-life. Efforts to optimize these paradigms are ongoing. In the last 30 years, significant innovations in drug delivery, scheduling and biologic therapies have resulted in significant improvements in disease-specific outcomet in the metastatic setting. One hopes that ongoing innovations, particularly in targeted therapy, will continue to translate into further improvements in this population.
Original language | English (US) |
---|---|
Pages (from-to) | 411-418 |
Number of pages | 8 |
Journal | Future Oncology |
Volume | 3 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2007 |
Externally published | Yes |
Keywords
- Breast cancer
- Chemotherapy
- Metastatic
ASJC Scopus subject areas
- Oncology
- Cancer Research